Additional, ALDH8A1, ALDOB and FAM110C are expected to be potential biomarkers of HCC, though further experimental verification is needed to confirm their potential prognostic value in HBV-positive HCC. This evidence concerns the gene FAM110C and hepatocellular carcinoma.